What is Barrett Zlotoff's NPI number?

Barrett Zlotoff's National Provider Identifier (NPI) is 1629161476, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Barrett Zlotoff's specialty?

Barrett Zlotoff is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Barrett Zlotoff located?

Barrett Zlotoff's practice location on file with NPPES is 1221 Lee St, Charlottesville, VA 22908-0001.

What is Barrett Zlotoff's phone number?

The practice phone number listed in the NPPES registry for Barrett Zlotoff is (434) 924-5115.

Does Barrett Zlotoff accept Medicare?

Barrett Zlotoff is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Barrett Zlotoff's NPI active?

Yes — Barrett Zlotoff's NPI (1629161476) is active in the NPPES registry as of the last update on 2023-08-09.

IndividualActiveAccepts Medicare

Barrett Zlotoff, M.D.

NPI 1629161476 · Dermatology Physician · Charlottesville, VA

Barrett Zlotoff, M.D. is a Dermatology Physician provider in Charlottesville, VA (NPI 1629161476).

Provider details

NPI number: 1629161476
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: MD20060477 (NM)

Practice location

1221 Lee St

Charlottesville, VA 22908-0001

Phone: (434) 924-5115

Fax: (434) 244-4504

Street-level locationGet directions

More VA providers

Mailing address

Po Box 9007

Charlottesville, VA 22906-9007

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101258272 (VA)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense MD20060477 (NM)
Allopathic & Osteopathic Physicians

Additional practice locations (2)

1215 Lee St
Charlottesville, VA 22908-0001
Phone: (434) 924-0211
1015 Spring Creek Pkwy
Zion Crossroads, VA 22942-7019
Phone: (434) 243-9466
Fax: (434) 243-9499

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(79/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
3 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
1,233 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	314	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	222	$63
Destruction of Precancer Skin Growth, 1 Growth17000	155	$46
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	111	$92
Biopsy of Related Skin Growth, First Growth11102	84	$26
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	34	13
Triamcinolone Acetonide	23	14
Clobetasol Propionate	22	—
Adalimumabbrand: Humira(cf) Pen	15	—
Tretinoin	14	—
Apremilastbrand: Otezla	13	—
Azathioprine	12	—
Clindamycin Phosphate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$15 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-10-02
Last updated: 2023-08-09
Certified: 2023-08-09

Frequently asked questions

What is Barrett Zlotoff's NPI number?: Barrett Zlotoff's National Provider Identifier (NPI) is 1629161476, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Barrett Zlotoff's specialty?: Barrett Zlotoff is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Barrett Zlotoff located?: Barrett Zlotoff's practice location on file with NPPES is 1221 Lee St, Charlottesville, VA 22908-0001.
What is Barrett Zlotoff's phone number?: The practice phone number listed in the NPPES registry for Barrett Zlotoff is (434) 924-5115.
Does Barrett Zlotoff accept Medicare?: Barrett Zlotoff is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Barrett Zlotoff's NPI active?: Yes — Barrett Zlotoff's NPI (1629161476) is active in the NPPES registry as of the last update on 2023-08-09.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	314	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	222	$63
Destruction of Precancer Skin Growth, 1 Growth17000	155	$46
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	111	$92
Biopsy of Related Skin Growth, First Growth11102	84	$26
Destruction of Skin Growth, 1-14 Growths

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

Triamcinolone Acetonide

Clobetasol Propionate

—

Adalimumabbrand: Humira(cf) Pen

—

Tretinoin

—

Apremilastbrand: Otezla

—

Azathioprine

—

Clindamycin Phosphate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$15 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (2)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (2)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments